Skip to main content

$0.056 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
3 July 2025 at 6:25pm
Register to track CDY and receive email alerts.
Subject
CDY Ann: Cellmid receives R&D tax credit

CDY Ann: Dispatch of Rights Issue Documentation Completed

CDY Ann: Investor Presentation

CDY Ann: Commencement of the Trading of Rights on the ASX

CDY Ann: Appendix 3B

CDY Ann: Rights Issue Prospectus

CDY Ann: Rights Issue

CDY Ann: Pause in Trading

CDY Ann: Appendix 4D and Half Year Report

CDY Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Cellmid Receives First Order From Chinese Distributor

CDY Ann: Appendix 2A

CDY Ann: Final Director's Interest Notice - King

CDY Ann: Change of Director's Interest Notice - Gordon

CDY Ann: Change of Director's Interest Notice - Halasz

CDY Ann: Change of Director's Interest Notice - King

CDY Ann: Confirming Changes to the Cellmid Board

CDY Ann: Newsletter

CDY Ann: Change of Director's Interest Notice - Eck

CDY Ann: Appendix 2A

CDY Ann: Cellmid Signs 10 Year Chinese Distribution Agreement

CDY Ann: Initial Director's Interest Notice - Eck-Thompson

CDY Ann: Final Director's Interest Notice - Walton

CDY Ann: Results of Meeting

CDY Ann: AGM Presentation to Shareholders

CDY Ann: Annual General Meeting - Change of Agenda

CDY Ann: Annual General Meeting Update

CDY Ann: Growth Strategy Presentation

CDY Ann: Release of Shares from Voluntary Escrow

CDY Ann: Letter to Shareholders - Notice of Annual General Meeting

CDY Ann: Notice of Annual General Meeting/Proxy Form

CDY Ann: Appendix 4C and Quarterly Activity Report

CDY Ann: Board Renewal To Align With Consumer Health Growth Strategy

Register to track CDY and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX